ISSCR News
Pluripotent Stem Cells Take Over From Blood Stem Cells for Future Transplant Therapies
New research published in Stem Cell Reports from Jinyong Wang and colleagues with the Chinese Academy of Sciences and Guangzhou Medical University has now optimized a combination of proteins, so-called transcription factors, which when introduced in mouse PSCs convert them to HSPCs in the dish. When transplanted into mice with impaired HSPCs, the PSC-derived cells generated all types of white blood cells over a period of 6 months. Importantly, the transplanted HSPCs did not give rise to tumors or leukemias in the receiving mice.
ISSCR Advocates for Stem Cell Research
The ISSCR is deeply committed to supporting and defending stem cell research by advocating for science-based legislative and regulatory policies. Our society has been a steadfast advocate for our international community for many years. The investment in our advocacy work, led by Public Policy Committee Chair Sean Morrison, offers the ISSCR increasing opportunities to shape conversations and inform policy.
Member Spotlight: Tamra Lysaght, PhD
“There are also many websites and businesses out there [falsely] claiming to be able to treat all sorts of ailments with so-called ‘stem cells’. [Our] research will help patients make informed decisions about the various options with their doctor that are in their best interests.”
Thomas A. Rando Receives the 2023 ISSCR Achievement Award
The International Society for Stem Cell Research (ISSCR) will award its 2023 ISSCR Achievement Award to Thomas A. Rando, M.D., Ph.D., director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and professor of Neurology and of Molecular, Cell, and Developmental Biology, UCLA, USA.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .